Literature DB >> 10767570

Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design.

G Stensrud1, S A Sande, S Kristensen, G Smistad.   

Abstract

The effect of different formulation factors (lipid type, cholesterol, charge, internal buffer capacity, drug-to-lipid incubation ratio) on the encapsulation efficiency and size of primaquine liposomes (SUV's) in response to a pH gradient was investigated by a fractional factorial screen ing design. Three of the factors (charge, internal buffer capacity, drug -to-lipid incubation ratio) were further studied in a Box--Behnken optimisation design. The lipid type was the most important parameter followed by the drug-to-lipid incubation ratio, buffer capacity, cholesterol and charge. Several of the interactions wer e important. In the optimisation design a robust region with high encapsulation efficiency (>95%) was obtained for DSPC: 33.33 mol% cholesterol-liposomes at high internal citrate concentration (200 mM) by maintaining the drug-to-lipid incubation ratio below 0.15:1 (mol:mol) and varying the charge incorporation between 2 and 10%. In order to achieve long-term stability and sterility, the liposomes were lyophilised followed by gamma irradiation. The pH gradient was maintained during this treatment with little chemical degradation of the substances. The final preparation consisted of three separate vials with lyophilised liposomes, solid state primaquine and hydration medium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767570     DOI: 10.1016/s0378-5173(00)00338-0

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs.

Authors:  C D Bertol; P R Oliveira; G Kuminek; G S Rauber; H K Stulzer; M A S Silva
Journal:  Ann Trop Med Parasitol       Date:  2011-10

2.  Quantitative structure-property relationship modeling of remote liposome loading of drugs.

Authors:  Ahuva Cern; Alexander Golbraikh; Aleck Sedykh; Alexander Tropsha; Yechezkel Barenholz; Amiram Goldblum
Journal:  J Control Release       Date:  2011-12-01       Impact factor: 9.776

3.  High-efficiency liposomal encapsulation of a tyrosine kinase inhibitor leads to improved in vivo toxicity and tumor response profile.

Authors:  Rajesh Mukthavaram; Pengfei Jiang; Rohit Saklecha; Dmitri Simberg; Ila Sri Bharati; Natsuko Nomura; Ying Chao; Sandra Pastorino; Sandeep C Pingle; Valentina Fogal; Wolf Wrasidlo; Milan Makale; Santosh Kesari
Journal:  Int J Nanomedicine       Date:  2013-10-21

4.  Liposomal 5-Fluorouracil Polymer Complexes Facilitate Tumor-Specific Delivery: Pharmaco-Distribution Kinetics Using Microdialysis.

Authors:  Wen Wang; Paul Joyce; Kristen Bremmell; Robert Milne; Clive A Prestidge
Journal:  Pharmaceutics       Date:  2022-01-18       Impact factor: 6.321

5.  Interactions of primaquine and chloroquine with PEGylated phosphatidylcholine liposomes.

Authors:  Andang Miatmoko; Ira Nurjannah; Nuril Fadilatul Nehru; Noorma Rosita; Esti Hendradi; Retno Sari; Juni Ekowati
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

Review 6.  Liposomes for malaria management: the evolution from 1980 to 2020.

Authors:  Patrick B Memvanga; Christian I Nkanga
Journal:  Malar J       Date:  2021-07-27       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.